Atlas Trials

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer

Clinical trial NCT00486460 · UNKNOWN

Trial details

NCT number
NCT00486460
Sponsor
Tel-Aviv Sourasky Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2005-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.